sanphamtin_tuy-chon-goodhealth-oyster MUA TINH CHT HU U UY TN, CHNH HNG
doi: 10.14309/ajg.0000000000003208 105 Ramos BelinchnCMartnez-LozanoHSerrano MorenoCHernndez CastilloDLois ChicharroPFerreira OcampoPet al
IGlarLixi is a fixed-ratio combination of insulin glargine and lixisenatide, containing 100 U/mL of glargine and 33 lg/mL of lixisenatide in a 3-mL prefilled injection pen
The semaglutide 1.0 mg group showed a weight reduction of 1.8% of body weight compared to 1.4% in the dulaglutide group, which used a 1.5 mg dose
Indian consumers addressing melasma, hyperpigmentation, or oxidative stress benefit most from pharmaceutical-grade liposomal formulations that ensure proper absorption
CrossRef Original Article Cardiovascular Risk/Epidemiology Clinical Significance of Body Fat Distribution in Coronary Artery Calcification Progression in Korean Population Heesun Lee, Hyo Eun Park, Ji Won Yoon, Su-Yeon Choi Diabetes Metab J